Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accumulated Expenses (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Accumulated Expenses readings, the most recent being $2.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 3.89% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a 3.89% decrease, with the full-year FY2025 number at $2.7 million, down 3.89% from a year prior.
  • Accumulated Expenses hit $2.7 million in Q4 2025 for Lucid Diagnostics, down from $2.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.8 million in Q4 2024 to a low of $10000.0 in Q4 2022.
  • Median Accumulated Expenses over the past 5 years was $901000.0 (2021), compared with a mean of $1.2 million.
  • Biggest five-year swings in Accumulated Expenses: tumbled 98.2% in 2022 and later surged 2846.88% in 2024.
  • Lucid Diagnostics' Accumulated Expenses stood at $557000.0 in 2021, then tumbled by 98.2% to $10000.0 in 2022, then skyrocketed by 860.0% to $96000.0 in 2023, then surged by 2846.88% to $2.8 million in 2024, then fell by 3.89% to $2.7 million in 2025.
  • The last three reported values for Accumulated Expenses were $2.7 million (Q4 2025), $2.8 million (Q4 2024), and $96000.0 (Q4 2023) per Business Quant data.